Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

about

Identification and functional analysis of glycemic trait loci in the China Health and Nutrition Survey.

P2860

Q52690721-5A301A32-1922-4A34-91EF-D276FB624780

P2860

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

Item

http://www.wikidata.org/entity/Q36905641

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Whole-exome tumor sequencing s ...... a response to MEK inhibitors.

@en

type

Item

label

Whole-exome tumor sequencing s ...... a response to MEK inhibitors.

@en

prefLabel

Whole-exome tumor sequencing s ...... a response to MEK inhibitors.

@en

P1476

Whole-exome tumor sequencing s ...... a response to MEK inhibitors.

@en

P2093

Baris Hancioglu

http://www.w3.org/2001/XMLSchema#string

Cynthia Timmers

http://www.w3.org/2001/XMLSchema#string

Daniel H Ahn

http://www.w3.org/2001/XMLSchema#string

Gregory B Lesinski

http://www.w3.org/2001/XMLSchema#string

Hatice Gulcin Ozer

http://www.w3.org/2001/XMLSchema#string

Tanios Bekaii-Saab

http://www.w3.org/2001/XMLSchema#string

P2860

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Cancer statistics, 2015

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor

Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers

From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline

Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.

P304

5306-5312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6632

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tanios Bekaii-Saab

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287482962

http://www.w3.org/2001/XMLSchema#string

P698

26683364

http://www.w3.org/2001/XMLSchema#string

P932

4868687

http://www.w3.org/2001/XMLSchema#string

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

about

P2860

P2860

Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932